DecisionPoint Financial LLC Acquires 62 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

DecisionPoint Financial LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 155.0% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 102 shares of the healthcare conglomerate’s stock after purchasing an additional 62 shares during the period. DecisionPoint Financial LLC’s holdings in UnitedHealth Group were worth $52,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. AMF Tjanstepension AB raised its holdings in shares of UnitedHealth Group by 88.0% in the 3rd quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock worth $151,374,000 after purchasing an additional 121,180 shares during the period. Hudson Value Partners LLC grew its stake in shares of UnitedHealth Group by 8.3% during the 3rd quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock worth $625,000 after acquiring an additional 82 shares during the period. Wealth Group Ltd. lifted its holdings in UnitedHealth Group by 4.0% during the third quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock valued at $1,039,000 after purchasing an additional 68 shares during the last quarter. Perfromance Wealth Partners LLC purchased a new stake in shares of UnitedHealth Group during the 3rd quarter valued at approximately $201,000. Finally, Annex Advisory Services LLC grew its stake in UnitedHealth Group by 2.7% in the 3rd quarter. Annex Advisory Services LLC now owns 41,955 shares of the healthcare conglomerate’s stock valued at $24,530,000 after buying an additional 1,110 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the topic of several analyst reports. Truist Financial decreased their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Bank of America cut their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. KeyCorp reiterated an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Morgan Stanley lowered their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $629.32.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $526.68 on Monday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a market cap of $484.69 billion, a price-to-earnings ratio of 33.98, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. The company has a 50-day moving average price of $529.18 and a 200-day moving average price of $564.37.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the prior year, the business earned $5.83 EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.